Clinical Trials Browser

Phase 4 × INDUSTRY × Unresectable Non-small Cell Lung Cancer (NSCLC) × Clear all

NCT04416633 2024-11-08

Study to Access Safety of Durvalumab in Indian Adult Patients With Locally Advanced NSCLC

Phase 4 Completed

100 enrolled 11 charts

Unresectable Non-small Cell Lung Cancer (NSCLC)